Depression drug: Pfizer sues Alembic, Breckenridge

Written by Press Trust of India | New Delhi | Updated: Jun 30 2012, 08:14am hrs
Alembic Pharma on Friday said Pfizer has filed a lawsuit against it and US firm Breckenridge Pharma for their move to market generic tablets for treating depression. The tablets in the strengths of 50 mg and 100 mg are generic versions of Pfizers Pristiq tablets.

Breckenridge Pharmaceuticals USA and Alembic Pharmaceuticals were named as co-defendants in a Paragraph IV lawsuit filed by Pfizer concerning their Anda for desvenlafaxine succinate extended release tablets...," Alembic Pharmaceuticals informed BSE.

Alembic is the sponsor and manufacturer of the abbreviated the new drug application (Anda), which will be marketed exclusively by Breckenridge, the company said. Both the companies filed their Paragraph IV Anda on the first possible submission date and expect to share 180 days exclusivity with other first filers, it added.